Cargando…
Regulation of CHK1 by mTOR contributes to the evasion of DNA damage barrier of cancer cells
Oncogenic transformation leads to dysregulated cell proliferation, nutrient deficiency, and hypoxia resulting in metabolic stress and increased DNA damage. In normal cells, such metabolic stress leads to inhibition of signaling through the mammalian Target of Rapamycin Complex 1 (mTORC1), reduction...
Autores principales: | Zhou, Xinhui, Liu, Weijin, Hu, Xing, Dorrance, Adrienne, Garzon, Ramiro, Houghton, Peter J., Shen, Changxian |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5431544/ https://www.ncbi.nlm.nih.gov/pubmed/28484242 http://dx.doi.org/10.1038/s41598-017-01729-w |
Ejemplares similares
-
P53 suppresses ribonucleotide reductase via inhibiting mTORC1
por: He, Zhengfu, et al.
Publicado: (2017) -
Predicted mechanisms of resistance to mTOR inhibitors
por: Kurmasheva, R T, et al.
Publicado: (2006) -
mTOR Signaling Upregulates CDC6 via Suppressing miR-3178 and Promotes the Loading of DNA Replication Helicase
por: Wu, Xianjin, et al.
Publicado: (2019) -
Exploiting the mTOR paradox for disease prevention
por: Iglesias-Bartolome, Ramiro, et al.
Publicado: (2012) -
Narrative review of emerging roles for AKT-mTOR signaling in cancer radioimmunotherapy
por: Shen, Changxian, et al.
Publicado: (2021)